Bristol-Myers Squibb Company (BVMF:BMYB34)

Brazil flag Brazil · Delayed Price · Currency is BRL
254.30
0.00 (0.00%)
At close: Aug 26, 2025
Market Cap527.69B
Revenue (ttm)259.93B
Net Income (ttm)27.51B
Shares Outn/a
EPS (ttm)13.55
PE Ratio19.18
Forward PE7.45
Dividend9.27 (3.65%)
Ex-Dividend DateJul 3, 2025
Volumen/a
Average Volume61
Open254.30
Previous Close254.30
Day's Range254.30 - 254.30
52-Week Range241.10 - 369.03
Beta0.37
RSI45.35
Earnings DateJul 31, 2025

About BVMF:BMYB34

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Sector Healthcare
Founded 1887
Employees 34,100
Stock Exchange Brazil Stock Exchange
Ticker Symbol BMYB34
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.